摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

stagonolide E | 1004760-98-8

中文名称
——
中文别名
——
英文名称
stagonolide E
英文别名
(3Z,5E,7R,10R)-7-hydroxy-10-methyl-7,8,9,10-tetrahydro-2H-oxecin-2-one;(2R,5R,6E,8Z)-5-hydroxy-2-methyl-2,3,4,5-tetrahydrooxecin-10-one
stagonolide E化学式
CAS
1004760-98-8
化学式
C10H14O3
mdl
——
分子量
182.219
InChiKey
SEURXENDYJJSDO-DKWSLFAKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    373.1±42.0 °C(Predicted)
  • 密度:
    1.081±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES
    申请人:Council of Scientific and Industrial Research
    公开号:US20150210665A1
    公开(公告)日:2015-07-30
    The present invention discloses organocatalytic process for asymmetric synthesis of highly enantioselective decanolide compounds in high yield with >99% ee. Further, the present invention disclose cost effective, improved organocatalytic process for asymmetric synthesis of highly enantioselective decanolides compounds from non-chiral, cheap, easily available raw materials.
    本发明公开了一种高效的有机催化过程,用于非对称合成高对映选择性的癸内酯化合物,产量高且对映体过量大于99%。此外,本发明还揭示了一种成本效益高、改进的有机催化过程,用于从非手性、便宜且易于获得的原料中非对称合成高对映选择性的癸内酯化合物。
  • Stereoselective Total Synthesis of Stagonolide E
    作者:Singanaboina Rajaram、Udugu Ramulu、Seema Aravind、Katragadda Suresh Babu
    DOI:10.1002/hlca.201400265
    日期:2015.5
    An efficient and highly stereoselective synthesis of stagonolide E (1) starting from the readily available hexane‐1,6‐diol (8) was accomplished, employing MacMillan α‐hydroxylation, Horner WadsworthEmmons olefination, (Z)‐selective StillGennari olefination, and Yamaguchi lactonization as key steps.
    stagonolide E的效率且高立体选择性合成(1)从容易获得的1,6-己二醇(起始8)中的溶液来完成,采用麦克米兰α羟基化,霍纳 沃兹沃思埃蒙斯烯,(Ž) -选择性仍然 Gennari烯烃化和Yamaguchi内酯化是关键步骤。
  • Stereoselective total synthesis of stagonolide E
    作者:Gowravaram Sabitha、P. Padmaja、P. Narayana Reddy、Surender Singh Jadav、J.S. Yadav
    DOI:10.1016/j.tetlet.2010.09.072
    日期:2010.11
    The first total synthesis of a 10-membered macrolide, stagonolide E is described from readily available 4-penten-1-ol. The synthetic strategy involves Jacobsen’s kinetic resolution, Sharpless epoxidation, Stille–Gennari, and Yamaguchi lactonization as key reactions.
    从容易获得的4-戊烯-1-醇中描述了10元大环内酯类的第一个全合成内酯。合成策略涉及Jacobson的动力学拆分,Sharpless环氧化,Stille–Gennari和Yamaguchi内酯化等关键反应。
  • Organocatalytic process for asymmetric synthesis of decanolides
    申请人:Council of Scientific and Industrial Research
    公开号:US09353077B2
    公开(公告)日:2016-05-31
    The present invention discloses organocatalytic process for asymmetric synthesis of highly enantioselective decanolide compounds in high yield with >99% ee. Further, the present invention disclose cost effective, improved organocatalytic process for asymmetric synthesis of highly enantioselective decanolides compounds from non-chiral, cheap, easily available raw materials.
    本发明揭示了一种有机催化过程,用于高产率地合成高对映选择性的十内酯化合物,其对映选择性>99%。此外,本发明还揭示了一种经济实惠、改进的有机催化过程,用于从非手性、廉价、易得的原料中合成高对映选择性的十内酯化合物。
  • Structure–Activity Relationships of Natural C-9-Methyl-Substituted 10-Membered Lactones and Their Semisynthetic Derivatives
    作者:Anatoly Fedorov、Vsevolod Dubovik、Sergey Smirnov、Leonid Chisty、Victor Khrustalev、Anton Slukin、Alena Alekseeva、Elena Stepanycheva、Igor Sendersky、Alexander Berestetskiy、Anna Dalinova
    DOI:10.1021/acs.jnatprod.3c01216
    日期:2024.4.26
    curvulides A (4) and B1/B2 (5a,b), and pyrenolide C (6)), were purified from cultures of the phytopathogenic fungus Stagonospora cirsii, and five semisynthetic derivatives of 3 and 4 (7–11) were obtained. The absolute configuration of 4 was revised to 2Z, 4S, 5S, 6R, and 9R. The identity of 5a,b and stagonolide H is discussed. The phytotoxicity of compound 4, the entomotoxicity of 5a,b, and nonselective toxicity
    真菌 10 元内酯 (TML),例如鹿角内酯 A、herbarumin I、pinolidoxin 和 putaminoxin,是开发天然除草剂的有希望的候选者。本研究的目的是通过多靶点生物测定方法分析 C-9-甲基取代的 TML 的结构-活性关系 (SAR),以揭示具有有用(植物毒性、昆虫毒性、抗菌)或不良(细胞毒性)生物活性的化合物。一种新的 TML,鹿角内酯 L ( 1 ),以及五种已知化合物(鹿角内酯 D ( 2 ) 和 E ( 3 )、弯花内酯 A ( 4 ) 和 B 1 /B 2 ( 5a , b ) 以及内酯 C ( 6 ) ),从植物病原真菌Stagonospora cirsii的培养物中纯化,获得了3和4 ( 7 – 11 ) 的五种半合成衍生物。 4的绝对构型修改为 2 Z 、 4 S 、 5 S 、 6 R和 9 R 。讨论了5a 、 b和雄鹿角内酯 H 的同一性。证明了化合物4的植物毒性、
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 17-苯基-18,19,20-三去甲-前列腺素F2-alpha1,15-内酯 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (R)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 8-Chlor-1,6-benzodioxocin 2,2,6-Trifluoro-4-phenyl-3-trifluoromethyl-2H-pyran 2,3,4,5,6,7-Hexahydro-1-benzoxonin aspinolide C 4-deutero-4,5-dihydro-2H-benzo[b]oxocin-6(3H)-one 3-Carbethoxy-4-bromo-5,6-dihydro-2-pyron (E,8S,13S)-8,13-diisopropyl-5,8,9,12,13,16-hexahydro-6,15-dioxa-benzocyclotetradecene-7,14-dione (1S,7Z,10R,11S)-11-t-butyldimethylsolyloxy-4-oxabicyclo[8.3.0]tridec-7-en-3-one (Z)-2-Methyl-3a,4,5,6,7,9a-hexahydro-cycloocta[b]furan-3-carboxylic acid ethyl ester (5R,8S,9R,10S,E)-5,8,9-trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one 19,21-Dimethyl-4,15-dioxa-bicyclo[16.2.2]docosa-1(21),18(22),19-triene-3,16-dione (1S,4aR,8aS)-1,4,4a,8a-Tetrahydro-naphthalen-1-ol 5-methyl-2-oxo-2H-cyclohepta[b]furan-3-carboxylic acid methyl ester trans,trans-2,3;10,11-Dibenzo-1,4,9,12-tetraoxa-cyclohexadecatetraen-(2,6,10,14) 1-C-(4-O-acetyl-2,3,6-trideoxy-β-L-erytro-hex-2-en-pyranosyl)-3-bromopentane 2,2,2-Trichloro-acetimidic acid (2S,3S,6R)-2-methoxy-6-methyl-3,6-dihydro-2H-pyran-3-yl ester 1-C-(4-O-acetyl-2,3,6-trideoxy-α-L-erytro-hex-2-en-pyranosyl)-5-bromopentane (3,4-dihydro-1H-2-benzopyran-7-yl)methanesulfonylchloride methyl 2,3-C-(2-butene-1,4-diyl)-2,3-dideoxy-α,β-D-talofuranoside 3-oxobicyclo<7.3.1>-trideca-1(12),9(10)-diene-(ZZ)-12-carboxylic acid (3aS,5S,6R,8aR)-6-Hydroxy-5-methyl-3,3a,4,5,6,8a-hexahydro-cyclohepta[b]furan-2-one (Z)-3-butyl-6,7,8,9-tetrahydrooxonin-2(5H)-one 3,6-dihydro-4-methyl-2H-1-benzoxocine 18,20-Dimethyl-4,14-dioxa-bicyclo[15.2.2]henicosa-1(20),17(21),18-triene-3,15-dione 3-butyl-5,6,7,8,9,10-hexahydro-2H-oxecin-2-one